DN Research / Sources you can keep
Published research files for analysts, journalists and builders. Link to the evidence behind a claim, preserve its date and carry its limitations into your work.
This directory covers the latest published Decision Brief snapshots, the Markets dataset, claim annotations, dated source follow-ups, comparison claim mappings and update mappings linked here. The underlying versioned files are fixed snapshots. Current research pages may evolve; cite the exact-version source when reproducibility matters.
Annotation and comparison-mapping dates describe publication; the update registry labels its latest linked publication separately. These dates do not refresh the original research. Review dates describe DN’s source review, not a provider release date. These files contain documentation research, not live prices, trading availability, independent audits or performance results. A newer publication does not automatically establish better or safer conditions.
The download is a JSON directory of links, versions, scope and citations. Follow each evidence JSON link to obtain the underlying file. No API key or account is needed to open these public snapshots.
26 of 26 assets shown.
ApeX Omni still separates funding from trading balances and requires distinct API/ZkLink signing controls. Current API docs now specify 8 cross-collateral assets, hourly funding, explicit private/order rate limits and separate actual-fee vs limit-fee fields.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Current documentation sharpens the comparison without producing a winner. ApeX Omni now exposes broader cross-collateral and API limits; EVEDEX clarifies hybrid gasless trading, broader markets and cashback timing; SAI now quantifies taker, trigger, rapid-close, borrowing and liquidation charges.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Aster Pro perpetuals still separate cross, isolated and multi-asset risk, but current docs now provide concrete 0.01% maker / 0.035% taker headline rates, Single-Asset collateral of USDT and USD1, Multi-Asset auto-exchange triggers and a documented 4% annualized negative-balance rate.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Claim-level evidence types, publisher origins and conditions that would change conclusions across 14 platform briefs.
Annotation publication is not a new source review. Preserve each referenced snapshot’s original review date and limitations.
Links published follow-ups to specific claim IDs and brief versions, with their documented implications.
A mapping is not a new review or a live monitoring service. The latest mapped publication date does not establish the registry’s publication date.
Follow related platform claims from six dated comparisons, with unmapped evidence gaps preserved.
Related claims may support only part of a comparison row. Navigation mappings do not constitute independent verification or refresh the underlying source-review dates.
Versioned AI-agent and autonomous-finance risk profiles with exposure classes, evidence confidence and recurring surveillance context.
Not a safety ranking, probability of safety, production certification or general performance benchmark. Different test surfaces are not directly comparable.
Crypto benchmarks, tokenised instrument structures, AI business exposure and institutional diligence questions.
Editorial documentation summaries, not live prices, performance data, execution observations or a licensed market feed.
EVEDEX still settles reviewed perpetuals in USDT and charges on executed notional, but current docs now show a much broader market set, hybrid gasless trading, next-day USDT cashback and expanded smart-account onboarding routes.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
GMX V2 still separates funding routes, market/pool collateral and execution. Current docs now make pool-specific price-impact caps, continuous/event-driven funding and borrowing, conditional margin deposits, network-fee handling and delegated-subaccount controls more explicit.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
The final three-way refresh sharpens product-scope and cost differences without producing a winner. GMX adds more explicit pool-impact/funding/borrowing controls, MUX now quantifies native V3 fees and borrowing, and SynFutures' current 2026 stack is broader than the historical V3 snapshot.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
GRVT still separates Single-Asset and Multi-Asset Margin, with USDT settlement and USDC collateral support under MAM. Current docs now specify CVRs, hourly borrowing, current 9-tier trading fees and MAM repayment charges, while withdrawal pages still differ slightly on route-fee presentation.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
DAI is documented as close-only on Arbitrum and Polygon. New-position collateral varies by network; Arbitrum also lists GNS. Verify the deployment and full cost breakdown.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Compare documented conditions without declaring a winner. Both snapshots describe USDC on Base, but Veranta fee sources conflict and neither brief measures comparable live execution or permission safety.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Account mode still controls how balances support perpetual trading. Current portfolio-margin documentation adds explicit eligibility thresholds, asset caps, LTVs, automated borrowing and idle-asset yield; unified and portfolio modes also carry a documented daily action limit.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Current documentation still supports a mode-first comparison, but both sides now expose more explicit conditionality: Hyperliquid portfolio margin has documented eligibility, caps, LTV and borrow/earn mechanics, while Lighter now distinguishes core Lighter collateral from a separate Robinhood Chain Lighter collateral table. No live cheapest, fastest or safest-platform conclusion is supported.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Standard accounts currently have zero maker/taker fees across perpetual and spot markets, while Plus and Premium/Advanced use paid tiers. Multi-asset margin remains UTA-only and now documents separate collateral parameters for core Lighter and Robinhood Chain Lighter, while the page still contains conflicting spot-availability language.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
MUX remains a suite that combines aggregator routing with native V3. Current docs now quantify native V3 costs more clearly, including 0.06% open/close position fees, hourly borrowing based on an 8% base annualized rate that can rise toward 40–50%, and a 0.06% liquidation fee.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
MYX V2 still ties maker/taker treatment to market imbalance rather than order type. Current docs now expose full rating/VIP fee tables and make Profit Lock dispute economics more concrete, including a 3,000 USD LP appeal bond.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Current documentation sharpens the comparison without producing an overall winner. MYX now exposes concrete rating/VIP fee tables and a 3,000 USD Profit Lock appeal bond; Aster now exposes headline Pro fees, Single-Asset collateral, Multi-Asset auto-exchange/interest terms and current TWAP limits.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Paradex still classifies orders by submission method rather than permanent user type. Current docs make the trade-offs explicit: Retail orders have 300 ms order/cancel speed bumps, much lower rate limits, zero fees across Perps/Spot/Options, RPI access and queue priority, while Pro orders use the API fee schedule and no speed bump.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Current documentation sharpens the comparison rather than producing an overall winner. Paradex Retail/Pro routing now has explicit speed bumps, limits and fee schedules; GRVT MAM now exposes CVRs, 9-tier trading fees and repayment charges. Both still leave live execution, permissions and user-specific eligibility unmeasured.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
SAI remains gasless on Nibiru for trading, but its current documentation now quantifies the full fee stack: 0.05% base taker, 0% maker, 0.01% trigger, variable borrowing, rapid-close penalties and a 10% liquidation penalty on remaining collateral.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
SynFutures still combines orderbook and AMM liquidity for perpetuals, but its 2026 product stack is broader than the original snapshot. Current official material references a newer mainnet architecture, API access and deployments including Base, Blast and Monad, so product and network scope must be checked before applying older workflow assumptions.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Veranta documents USDC margin on Base and session-based trading permissions. Its fee pages disagree on maker rates and Upside borrowing costs. Treat zero-commission claims as product-specific; no definitive total-cost comparison or live security assessment is established.
Documentation research, not a live execution test, safety rating or eligibility decision. Preserve the full snapshot’s sources, unknowns and disclosures.
Access gaps resolved for these four retrieved pages; fee inconsistencies and live validation remain unresolved.
No live trading, collateral, permission or payout tests. No user-specific eligibility assessment. Other sources in the original snapshot were not reverified by this follow-up. A content hash identifies the retrieved text, not its truth, authenticity or future availability.
